Abstract Accurate quantification of host cell proteins (HCPs) is essential for the safety and quality control of biopharmaceuticals. Although enzyme-linked immunosorbent assay (ELISA) remains the current industry gold standard, heterogeneity among the polyclonal antibody repertoires of different commercial kits often results in substantial method-dependent bias. This study aimed to establish a novel strategy for the quality evaluation of HCP detection kits for biologics.
Ping Lyu
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ping
Contact Ping, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack